BioSenic S.A. (BIOS.BR)

EUR 0.0

(0.0%)

Net Debt Summary of BioSenic S.A.

BioSenic S.A.'s latest annual net debt in 2023 was 28.04 Million EUR , up 47.69% from previous year.
BioSenic S.A.'s latest quarterly net debt in 2024 Q1 was 24.86 Million EUR , down -11.33% from previous quarter.
BioSenic S.A. reported annual net debt of 18.98 Million EUR in 2022, up 68.21% from previous year.
BioSenic S.A. reported annual net debt of 11.28 Million EUR in 2021, up 7475.84% from previous year.
BioSenic S.A. reported quarterly net debt of 24.86 Million EUR for 2024 Q2, up 4.47% from previous quarter.
BioSenic S.A. reported quarterly net debt of 28.04 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of BioSenic S.A. (2023 - 2011)

Historical Annual Net Debt of BioSenic S.A. (2023 - 2011)

Year	Net Debt	Net Debt Growth
2023	28.04 Million EUR	47.69%
2022	18.98 Million EUR	68.21%
2021	11.28 Million EUR	7475.84%
2020	149 Thousand EUR	-97.07%
2019	5.08 Million EUR	8.61%
2018	4.67 Million EUR	37.95%
2017	3.39 Million EUR	142.97%
2016	-7.89 Million EUR	62.74%
2015	-21.17 Million EUR	-387.47%
2014	7.36 Million EUR	136.05%
2013	3.12 Million EUR	706.02%
2012	-515 Thousand EUR	77.77%
2011	-2.31 Million EUR	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	24.86 Million EUR	-11.33%
2024 Q2	24.86 Million EUR	4.47%
2023 Q4	28.04 Million EUR	0.0%
2023 Q3	28.04 Million EUR	14.39%
2023 FY	28.04 Million EUR	47.69%
2023 Q1	24.22 Million EUR	27.58%
2023 Q2	24.51 Million EUR	1.21%
2022 Q4	18.98 Million EUR	-13.48%
2022 FY	18.98 Million EUR	68.21%
2022 Q2	15.94 Million EUR	0.0%
2022 Q3	21.94 Million EUR	37.68%
2021 Q2	6.53 Million EUR	0.0%
2021 Q4	11.28 Million EUR	0.0%
2021 FY	11.28 Million EUR	7475.84%
2020 FY	149 Thousand EUR	-97.07%
2020 Q4	149 Thousand EUR	0.0%
2020 Q2	11.89 Million EUR	0.0%
2019 Q4	5.08 Million EUR	0.0%
2019 Q2	2.84 Million EUR	0.0%
2019 FY	5.08 Million EUR	8.61%
2018 Q2	4.25 Million EUR	0.0%
2018 FY	4.67 Million EUR	37.95%
2018 Q4	4.67 Million EUR	0.0%
2017 Q4	3.39 Million EUR	0.0%
2017 FY	3.39 Million EUR	142.97%
2017 Q2	-851 Thousand EUR	0.0%
2016 Q2	-13.7 Million EUR	0.0%
2016 Q4	-7.89 Million EUR	0.0%
2016 FY	-7.89 Million EUR	62.74%
2015 Q2	-27.71 Million EUR	0.0%
2015 Q4	-21.17 Million EUR	0.0%
2015 FY	-21.17 Million EUR	-387.47%
2014 Q4	7.36 Million EUR	10.17%
2014 Q3	6.68 Million EUR	0.0%
2014 FY	7.36 Million EUR	136.05%
2013 FY	3.12 Million EUR	706.02%
2013 Q4	3.12 Million EUR	0.0%
2012 FY	-515 Thousand EUR	77.77%
2011 FY	-2.31 Million EUR	0.0%

Peer Net Debt Comparison of BioSenic S.A.

Name	Net Debt	Net Debt Difference
Nicox S.A.	13.89 Million EUR	-101.843%
European Medical Solutions	13.93 Million EUR	-101.306%
FERMENTALG	4.19 Million EUR	-568.829%
argenx SE	-1.83 Billion EUR	101.527%
Celyad Oncology SA	-6.1 Million EUR	559.587%
Hyloris Pharmaceuticals SA	-25.11 Million EUR	211.676%
Onward Medical N.V.	-12.89 Million EUR	317.497%
Oxurion NV	10.71 Million EUR	-161.849%
PHAXIAM Therapeutics S.A.	-275 Thousand EUR	10297.818%
Financière de Tubize SA	78.62 Million EUR	64.332%
UCB SA	2.17 Billion EUR	98.712%